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Abstract
Background: Limited information is available regarding the effect of age on choice of surgical and
oncological treatment for rectal cancer. The objective of this study was to assess the influence of
age on treatment and outcome of rectal cancer.
Methods: We utilized data in the Swedish Rectal Cancer Registry (SRCR) from patients treated
for rectal cancer in Sweden in 1995–2004.
Results: A total of 15,104 patients with rectal cancer were identified, 42.4% of whom were 75
years or older. Patients ≥75 years were less likely to have distant metastases than younger patients
(14.8% vs. 17.8%, P < 0.001), and underwent abdominal tumor resection less frequently (68.5% vs.
84.4%, P < 0.001). Of 11,725 patients with abdominal tumor resection (anterior resection [AR],
abdominoperineal excision [APE], and Hartmann's procedure [HA]), 37.4% were ≥75 years.
Curative surgery was registered for 85.0% of patients ≥ 75 years and for 83.9% of patients < 75
years, P = 0.11. Choice of abdominal operation differed significantly between the two age groups
for both curative and non-curative surgery, The frequency of APE was similar in both age groups
(29.5% vs. 28.6%), but patients ≥75 years were more likely to have HA (16.9% vs. 4.9%) and less
likely to have preoperative radiotherapy (34.3vs. 67.2%, P < 0.001). The relative survival rate at five
years for all patients treated with curative intent was 73% (70–75%) for patients ≥75 years and 78%
(77–79%) for patients < 75 years of age. Local recurrence rate was 9% (8–11%) for older and 8%
(7–9%) for younger patients.
Conclusion: Treatment of rectal cancer is influenced by patient's age. Future studies should
include younger and older patients alike to reveal whether or not age-related differences are
purposive. Local recurrence following surgery for low tumors and quality of life aspects deserve
particular attention.
Background
Rectal cancer predominantly affects persons over the age
of 50. The annual number of rectal cancer cases diagnosed
in Sweden has increased over the last twenty years, mainly
due to the increasing age of the Swedish population, a
trend that is expected to continue [1,2]. Previous studies
indicate that there is less inclination to perform surgery
and adjuvant oncological treatment in elderly patients [3-
Published: 26 February 2009
BMC Cancer 2009, 9:68 doi:10.1186/1471-2407-9-68
Received: 4 May 2008
Accepted: 26 February 2009
This article is available from: http://www.biomedcentral.com/1471-2407/9/68
© 2009 Jung et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Cancer 2009, 9:68 http://www.biomedcentral.com/1471-2407/9/68
Page 2 of 8
(page number not for citation purposes)
5]. There is, however, mounting evidence that fit, elderly
patients may benefit from surgery and adjuvant oncologi-
cal treatment in much the same way as younger patients
[6-8].
Since it began in 1995, the Swedish Rectal Cancer Registry
(SRCR) has prospectively registered nearly 100% of
patients diagnosed with rectal cancer in Sweden, along
with data describing choice of surgical strategy, postoper-
ative morbidity and mortality, neoadjuvant treatment,
and long-term survival[9]. The degree of coverage in the
SRCR is 98–100% of patients with an adenocarcinoma of
the rectum.
The aim of this audit was to investigate the influence in
Sweden of age on choice of surgical strategy, use of preop-
erative radiotherapy, and outcome following abdominal
surgery to treat rectal cancer.
Methods
All patients in the SRCR diagnosed from 1995 through
2004 were divided into two groups: ≥75 years and < 75
years of age at diagnosis. Abdominal tumor resection was
defined as anterior resection (AR), abdominoperineal
excision (APE), and Hartmann's procedure (HA). Cohorts
used and outcomes (parentheses) analyzed are summa-
rized below.
1995–2004: Patients with rectal cancer diagnosis, N  =
15,104 (distant metastases [yes/no]). Abdominal tumor
resection, N = 11,725 (tumor stage). Curative/noncura-
tive surgery known, N  = 11,510. Curative surgery N =
9,705 (tumor location, preoperative radiotherapy, reoper-
ation at 30 days, relative survival 90 days following sur-
gery, and relative 5-year survival).
Curative surgery was defined as a local radical procedure
(R0) with tumor-negative resection margins in patients
with no sign of distant metastases, according to UICC.
The study was approved by the Ethics Committee of the
University of Umeå, Sweden (05-097M).
Statistics
The chi-square test was used to test differences between
proportions. Two-tailed P values < 0.05 were considered
significant. SPSS v 13.0 (SPSS Inc, Chicago Illinois) soft-
ware was used for statistical analyses. The statistical pro-
gram Relsurv version 1.0 [10] was utilised for analysis of
relative survival, using data from the SRCR matched with
data from The National Board of Health and Welfare's
vital statistics [1,2]. Local recurrence was calculated
according to Kaplan-Meier with censoring of patients
deceased before 31 December 2001 or with rectal cancer
diagnosis after December 2001. This time was chosen as
end point because all patients undergoing surgery for rec-
tal cancer with curative intent are checked for local recur-
rence five years after surgery by Swedish Regional
Oncologic Centres, and patients treated after December
2001 had not yet completed this control.
Data are presented as mean (95% confidence interval).
Results
Tumor stage versus age and treatment
Between 1 January 1995 and 31 December 2004, 15,104
patients diagnosed with rectal cancer were identified in
the SRCR. Of these, 42.4% were ≥75 years of age at diag-
nosis. The median age of patients ≥75 years was 80 years,
and the median age was 65 years for those younger than
75 years. There was a lower proportion of men in the older
group (54.1%) compared with the younger group
(59.5%), P < 0.001. Among 6,407 patients ≥75 years (of
total 15,104), 946 (14.8%) had distant metastases at diag-
nosis compared with 1,550 of 8,697 patients (17.8%) <
75 years of age, P < 0.001. Altogether, 11,725 of 15,104
patients (77.6%) had an abdominal tumor resection;
4,388 of 6,407 patients ≥75 years (68.5%), and 7,337 of
8,697 patients < 75 years (84.4%), P < 0.001.
Tumor stage distribution according to age group among
those who underwent abdominal surgery is shown in
Table 1. Information on tumor stage was missing for 170
patients (1.5%); 74 of those who underwent AR (1.1%),
59 of those who underwent APE (1.7%), and 37 of those
who underwent HA (2.4%). Older patients were less likely
to have Stage IV disease than younger patients (10.3% vs.
13.4%,  P  < 0.001). Patients who underwent HA were
more likely to have Stage IV disease (27.9%) compared
with patients who underwent AR (9.8%) or APE (10.3%).
A total of 84.3% of patients were assessed by the surgeon
as having an R0 resection: 85.0% in the older group and
83.9% in the younger group, P = 0.11. Two hundred and
fifteen patients were excluded from further analysis due to
incomplete information concerning curative and noncur-
ative surgery. Thus, 11,510 patients were eligible for eval-
uation of perioperative and postoperative data
(reoperation rate at 30 days, relative survival at 90 days
following surgery and relative survival at 5 years).
As shown in Table 2, the surgical strategy for abdominal
resection varied with patient age. The percentage of APE
was similar in the two age groups both for curative and
noncurative operations. AR was less commonly per-
formed in elderly patients, whereas the reverse was true
for HA. These age-related differences were more pro-
nounced for curative surgery, but they were also signifi-
cant for noncurative surgery.BMC Cancer 2009, 9:68 http://www.biomedcentral.com/1471-2407/9/68
Page 3 of 8
(page number not for citation purposes)
Table 3 illustrates the proportion of low tumors (tumor
0–6 cm from the anal verge) for each surgical procedure in
the two age groups. In the majority of cases for both age
groups, APE was chosen as surgical strategy for low tumors
(0–6 cm from anal verge), AR was used slightly but signif-
icantly less for low tumors among older patients, 10.1%
versus 12.9% for younger patients, P  < 0.003. Table 4
illustrates the use of preoperative radiotherapy for
patients treated with curative intent in the two age groups.
As can be seen, older patients received preoperative radio-
therapy less frequently than younger patients regardless of
the surgical technique used, overall 34.3% versus 67.2%,
for patients having curative surgery P < 0.001.
Reoperation within 30 days of curative surgery was per-
formed in 340 of 3,663 patients (9.3%) ≥75 years and in
642 of 6,042 patients (10.3%) < 75 years, P = 0.036. The
reoperation rate for each procedure did not, however, dif-
fer significantly between the age groups.
Relative survival
Relative survival 90 days postoperatively was slightly but
significantly lower for older patients compared with
younger patients following curative abdominal tumor
resection: AR 96% (95–97%), mean (95% CI) vs. 99%
(98.6–99.4%); APE 97% (96–98%) vs. 99% (98.5–
99.5%); and HA 94% (92–96%) vs. 98%(96.7–100%).
For all patients ≥75 years, relative survival 90 days follow-
ing surgery was 96% (95–97%) compared with 99%
(98.7–99.3%) for younger patients.
For all 15,104 patients registered in SRCR 1995–2004, the
relative five-year survival was 62% (61–63%) for patients
< 75 years vs. 52% (50–54%) for patients ≥75 years.
Table 1: Type of operation and tumor stage versus age of patients with abdominal tumor resection (N = 11,725)
Operation Tumor stage < 75 years of age ≥ 75 years of age P value
AR N = 4,514 N = 2,235 0.001
Stage I-III 3,980 (88.2) 2,035 (91.1)
Stage IV 475 (10.5) 185 (8.3)
Stage not known 59 (1.4) 15 (0.6)
APE N = 2181 N = 1,277 0.001
Stage I-III 1,887 (86.5) 1,155 (90.4)
Stage IV 246 (11.3) 111 (8.7)
Stage not known 48 (2.2) 11 (0.9)
HA N = 642 N = 876 < 0.001
Stage I-III 362 (56.4) 696 (79.5)
Stage IV 266 (41.4) 157 (17.9)
Stage not known 14 (2.2) 23 (2.6)
Abdominal surgery N = 7,337 N = 4,388 < 0.001
Stage I-III 6,229 (84.9) 3,886 (88.6)
Stage IV 987 (13.4) 453 (10.3)
Stage not known 121 (1.7) 49 (1.1)
Values are absolute numbers with percentages given in brackets. Chi-squared test used for analysis of difference between age groups. AR, anterior 
resection. APE, abdominoperineal excision. HA, Hartmann's procedure.
Table 2: Choice of operation for curatively and noncuratively treated patients (N = 11,510).
Operation < 75 years ≥ 75 years All patients
Curative surgery N = 6,042 N = 3,663 N = 9,705
AR 3,965 (65.6) 1,998 (54.5) 5,963 (61.4)
APE 1,783 (29.5) 1,047 (28.6) 2,830 (29.2)
HA 294 (4.9) 618 (16.9) 912 (9.4)
Noncurative surgery N = 1,160 N = 645 N = 1,805
AR 485 (41.8) 214 (33.2) 699 (38.7)
APE 350 (30.2) 208 (32.2) 558 (30.9)
HA 325 (28.0) 223 (34.6) 548 (30.4)
Total 7,202 4,308 11,510
Values are absolute numbers with percentages given in brackets.
P < 0.001 for both curative and noncurative surgery. Chi-squar test was used for analysis of difference between age groups. AR, anterior resection. 
APE, abdominoperineal excision. HA, Hartmann's procedure.BMC Cancer 2009, 9:68 http://www.biomedcentral.com/1471-2407/9/68
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For all patients with abdominal tumor resection the rela-
tive five-year survival (95% confidence interval) was 68%
(67–69%) for patients < 75 years vs. 64% (61–66%) for
patients  ≥75 years. Among patients who underwent
abdominal tumor resection with curative intent from
1995 through 2004 (N = 9,705), relative five-year survival
was significantly lower for those ≥75 years compared with
patients < 75 years, 73% (70–75%) vs. 78% (77–79%).
For the specific abdominal operations, there was a ten-
dency towards lower relative survival for APR in the eld-
erly (although with overlapping 95% confidence limits),
(Figure 1).
Local recurrence
Local recurrence rate was 8% (7–9%) for patients < 75
years and 9% (8–11%) for those ≥ 75 years with no signif-
icant difference between the age groups, see Figure 2.
There was no significant difference in this respect between
the two age groups for any of the three abdominal tumour
resection procedures, see Table 5.
Discussion
The main findings in this study can be summarized as fol-
lows: Among patients 75 years or older, distant metastases
were diagnosed less frequently than in younger patients.
Older patients underwent abdominal surgery less fre-
quently but they had more HA:s than younger patients.
Preoperative radiotherapy was used for 34% of patients
≥75 years, compared with 67% of younger patients. Older
patients had lower relative survival 90 days postopera-
tively and lower relative five-year survival among all
patients, among patients with abdominal tumor resec-
tion, and among patients with curative operation. Local
recurrence rate did not, however, differ significantly
between the two age groups.
The SRCR covers nearly 100% of rectal cancer patients in
Sweden, providing an adequate description of the man-
agement of rectal cancer in a defined population[9]. It has
the possibility to use person-numbers, unique for each
resident in Sweden. The register is validated and the qual-
ity of data has been shown to be acceptable. This makes
descriptive data from this register of interest when plan-
ning studies validating future treatment programs for rec-
tal cancer. The SRCR is nationwide and therefore the data
input is limited to ensure acceptable registration compli-
ance. American Association of Anesthesiologists (ASA)
classification has been added to the registry in 2007. This
information could have been helpful in trying to under-
stand some of the results of our study, since older patients
are expected to have more comorbidity, as shown in pre-
vious studies [11-13].
Local recurrence rate in our audit was calculated using a
cohort different from the main cohort. The reason for this
is the method of gathering information about local recur-
rence from colorectal units to Regional Oncologic Centres
yearly, asking for local recurrence data for every patient
five years post year of surgery.
The choice of surgical strategy for tumors more than 6 cm
from the anal verge differed substantially between the
older and younger age groups. HA was chosen more often
for older patients with less advanced disease, which does
Table 3: Low tumors (0–6 cm from anal verge; N = 3445) versus type of operation and age in curatively treated patients (N = 9705).
< 75 years of age Low tumors 
(N = 2145)/curatively treated (N = 6042)
≥ 75 years of age Low tumors 
(N = 1114)/Curatively treated (N = 3663)
P-value
AR 510/3965 202/1998 0.003
APE 1560/1783 912/1047 0.86
HA 75/294 186/618 0.19
Values are absolute numbers of patients with low tumor for each surgical procedure vs. age group. Chi-square test used for statistical analysis. AR, 
anterior resection. APE, abdominoperineal excision. HA, Hartmann's procedure.
Table 4: Use of preoperative radiotherapy versus surgical procedure and age in curatively treated patients (N = 9705).
Curative surgery < 75 years of age
N = 6,042
≥ 75 years of age
N = 3,663
P-value
Preoperative radiotherapy 4,061 (67.2) 1,255 (34.3) P < 0.001
AR 2,436/3,965 (61.4) 635/1,998 (31.8) P < 0.001
APE 1,457/1,783 (81.7) 495/1,047 (47.3) P < 0.001
HA 168/294 (57.1) 125/618 (20.2) P < 0.001
Values are absolute numbers of patients receiving radiotherapy for each surgical procedure versus age group. Percentage given in brackets. Chi-
square test used for analysis of difference between age groups. AR, anterior resection. APE, abdominoperineal excision. HA, Hartmann's 
procedure.BMC Cancer 2009, 9:68 http://www.biomedcentral.com/1471-2407/9/68
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Relative five-year survival rate (95% confidence interval) for patients curatively treated with abdominal surgery for rectal can- cer 1995–2004 Figure 1
Relative five-year survival rate (95% confidence interval) for patients curatively treated with abdominal sur-
gery for rectal cancer 1995–2004. N = 9,705 (of 11,510 curative and noncurative operations). AR, anterior resection. APE, 
abdominoperineal excision. HA, Hartmann's procedure.
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not concur with a previous report, where sphincter saving
surgery was used in the majority of patients in both age
groups[8]. This is the most likely explanation for the ten-
dency towards a better five-year relative survival rate in
older patients compared with younger patients treated
with HA in our audit. The preference for HA in elderly
patients in our audit, as well as in a study from Nor-
way[14], could be due to concern about the functional
result (risk for fecal incontinence) after restorative surgery
in older patients. There is some evidence that the func-
tional result after AR is acceptable in older patients[15],
and chronological age alone should not exclude patients
from restorative surgery for rectal cancer. However, avail-
able studies comparing quality of life in patients treated
for rectal cancer with a permanent stoma (HA) and restor-
ative surgery (AR) do not demonstrate a significant differ-
ence between the two alternatives [16,17]. Further
prospective studies in this aspect are important, since the
short-term and long-term survival did not differ signifi-
cantly between patients in the AR and HA groups in our
audit.
A slightly lower relative survival at 90 days for elderly
patients highlights the physiological age limit for major
abdominal surgery. Although the reoperation rate differed
very little between the age groups, one may anticipate that
reoperation imposes a greater risk in elderly patients com-
pared with younger patients. Older patients who under-
went abdominal tumor resection had a less favorable
relative five-year survival than younger patients (64% vs.
68%), in spite of less advanced tumor stage (10.3 vs 13.4
stage IV). The five-year relative survival was also lower for
older patients than for younger patients treated with cura-
tive intent. It is of special interest that preoperative radio-
therapy prior to APE was used in 47% of patients ≥ 75
years, compared with 82% in younger patients. However,
no significant difference in the five-year local recurrence
rate after APE was seen. This indicates that preoperative
radiotherapy alone cannot entirely explain the slightly
worse five-year relative survival in older patients.
The total mesorectal excision technique (TME) [18-22]
was introduced in Sweden during the latter half of the
1990s after initial studies[23]. A similar introduction took
place during the same period in Norway[17,24]. The
impact of the TME technique in reducing the local recur-
rence rate is evident from population-based educational
programs[22,24]. There is ongoing discussion regarding
the need for improvement in APE surgical techniques for
better local control in order to improve outcome and pos-
sibly to reduce the need for preoperative radiother-
apy[9,25]. Population-based studies with prospective
detailed registration of surgical technique may shed light
on this important issue.
The extent to which preoperative radiotherapy should be
used in rectal cancer treatment is controversial. Preopera-
tive radiotherapy is known to improve local control but it
also increases the probability of fecal incontinence, sexual
dysfunction, and late hospital admission [26-31]. Nega-
tive side effects have been more pronounced in older
patients, as was shown in the Stockholm I and II tri-
als[32,33]. This is probably one factor explaining the low
rate of preoperative radiotherapy in the older age group in
our audit. However, it should be noted that modern radi-
otherapy has a higher tolerability than techniques used in
previous trials. Further studies, preferably with a cost-ben-
efit approach, concerning preoperative radiotherapy are
needed.
Conclusion
A higher threshold for resectional surgery was seen in eld-
erly patients, who were less likely to have stage IV disease
at operation. This age-dependent difference in tumor
stage was identified in all operations. It was most pro-
nounced for HA, frequently used in elderly patients. Five-
year relative survival was lower for all elderly patients and
for elderly patients treated with curative intent, whereas
local recurrence rate was comparable in the two age
groups. In order to improve outcomes for patients with
rectal cancer both population-based studies and trials
comprising older and younger patients, with emphasis on
physiological and quality-of-life aspects, are needed.
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